NIH ODS: Omega-3 Fatty Acids—Health Professional Fact Sheet
EPA and DHA have physiological roles; triglyceride treatment and general prevention are different questions.
Original sourceLiving source
THE INGREDIENTS
Omega-3
Formulation and indication matter
Original conceptual model
FormulationEPA / DHA
Study population
Triglycerides
≠
Clinical events
Different questions
Do not equate the endpoints
View the full-width diagram
Swipe horizontally to explore the diagram at its original size.
Read diagram relationships
- Formulation — EPA / DHA
- Study population
- Triglycerides ≠ Clinical events
Fish, EPA/DHA supplements and prescription products are related but distinct.
The mechanism
Omega-3 fatty acids participate in cell membranes and lipid signaling.
Where it may apply
Compare evidence for a defined clinical purpose with evidence for general prevention.
Limits & context
VITAL found no significant reduction in its primary cardiovascular composite or cancer outcome.
Context before use
High-dose studies have raised atrial-fibrillation concerns. Medicines and clinical context affect risk.
UPSTREAM
Research sources
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Marine omega-3 did not significantly reduce the primary composite cardiovascular outcome or invasive cancer.
Original source2019
CONNECTED PEOPLE
Related people to explore
These are thematic connections, not endorsements of every use described here.
RESEARCH & LEARNING
Take the question further
Do ordinary fish-oil capsules prevent a first cardiovascular event?
Learn why omega-3 biology, eating fish and taking a capsule are related but distinct questions.
2 source recordsRead the lesson